Ligand validation:6DWM

CPS: 3-[(3-CHOLAMIDOPROPYL)DIMETHYLAMMONIO]-1-PROPANESULFONATE

CPS is a Ligand Of Interest in 6DWM designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6DWM_CPS_A_603	10%	24%	0.355	0.914	1.05	2.02	3	16	0	0	74%	0.7381
6DWM_CPS_D_603	10%	21%	0.309	0.863	1.11	2.16	3	17	0	0	71%	0.7143
6UDM_CPS_A_603	10%	22%	0.373	0.878	1.13	2.1	2	24	0	0	100%	1
6DWN_CPS_A_603	4%	25%	0.357	0.817	1.01	2.02	1	15	0	0	62%	0.619
5FEZ_CPS_A_402	96%	34%	0.057	0.967	1.46	1.15	7	5	0	0	100%	0.9571
3IIX_CPS_A_1701	95%	46%	0.058	0.963	1.33	0.76	1	-	0	0	100%	0.9571
5FF3_CPS_A_402	94%	30%	0.078	0.979	1.58	1.21	3	6	0	0	100%	0.9571
5FEW_CPS_A_402	94%	23%	0.074	0.973	2.03	1.14	7	7	0	0	100%	0.9571
5FES_CPS_A_402	94%	22%	0.069	0.967	1.93	1.35	9	10	0	0	100%	0.9571

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.